SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ami Organics inches up on getting nod to enhance capital expenditure for brownfield project

13 Dec 2024 Evaluate

AMI Organics is currently trading at Rs. 2140.00, up by 6.40 points or 0.30% from its previous closing of Rs. 2133.60 on the BSE.

The scrip opened at Rs. 2111.05 and has touched a high and low of Rs. 2179.75 and Rs. 2106.90 respectively. So far 3065 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2320.00 on 02-Dec-2024 and a 52 week low of Rs. 1005.05 on 13-Mar-2024.

Last one week high and low of the scrip stood at Rs. 2295.00 and Rs. 2106.90 respectively. The current market cap of the company is Rs. 8760.59 crore.

The promoters holding in the company stood at 35.97%, while Institutions and Non-Institutions held 33.80% and 30.23% respectively.

Ami Organics has received approval from board of directors to enhance capital expenditure amounting upto total cost of Rs 177 crore for its brownfield project of electrolytes additives products at Jhagadia facility, owing to additional expenditure required for building dedicated ancillary infrastructures which includes transforming manual Operations to fully automised operations, building of dedicated utilities and storage & packaging facility.

Ami Organics is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.


Acutaas Chemicals Share Price

2596.55 96.05 (3.84%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×